SCHEMBL1669231

SCHEMBL1669231

CC(C)NCCCn1c(Sc2cc3c(cc2-c2ccco2)CCO3)nc2c(N)ncnc21

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 12/20 0.60
HSP90AB1 P08238 7/20 0.60
HSP90B1 P14625 6/20 0.60
TRAP1 Q12931 6/20 0.60
ERBB2 P04626 5/20 0.60
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18203356 0.97 HSP90AA1 (0.58) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL11908304 0.96 HSP90AA1 (0.59) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL11908601 0.94 HSP90AA1 (0.57) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL1670252 0.93 HSP90AA1 (0.65) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL18203282 0.90 HSP90AA1 (0.59) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL11909956 0.90 HSP90AA1 (0.59) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL1669663 0.90 HSP90AA1 (0.72) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL18203394 0.89 HSP90AA1 (0.59) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL11909342 0.88 HSP90AA1 (0.58) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2
SCHEMBL17770976 0.88 HSP90AA1 (0.69) HSP90AA1HSP90AB1HSP90B1TRAP1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091019-B1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS SLOAN KETTERING INST CANCER RES (US) 2019-04-03 EP disclosed
EP-3091019-A2 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS Sloan Kettering Institute For Cancer Research (US) 2016-11-09 EP disclosed
EP-2486039-A1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS Sloan Kettering Institute For Cancer Research (US) 2012-08-15 EP disclosed
WO-2011044394-A1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2011-04-14 WO disclosed